| NCT03195023 |
Effect of RAS Blockers on CKD Progression in Elderly Patients With Non Proteinuric Nephropathies (PROERCAN01) |
https://ClinicalTrials.gov/show/NCT03195023 |
Recruiting |
Hospital General Universitario Gregorio Marañon |
2019-12-31 |
| NCT03190694 |
Effects of Dapagliflozin in Non-diabetic Patients With Proteinuria |
https://ClinicalTrials.gov/show/NCT03190694 |
Active, not recruiting |
University Medical Center Groningen |
2019-11-01 |
| NCT02633046 |
Acthar for Treatment-Resistant or Treatment-Intolerant Proteinuria |
https://ClinicalTrials.gov/show/NCT02633046 |
Active, not recruiting |
Mallinckrodt |
2020-08-28 |
| NCT02599532 |
Pharmacokinetics of Apixaban in Nephrotic Syndrome |
https://ClinicalTrials.gov/show/NCT02599532 |
Completed |
University of North Carolina, Chapel Hill |
2019-06-28 |
| NCT02373241 |
Preventing Sickle Cell Kidney Disease |
https://ClinicalTrials.gov/show/NCT02373241 |
Active, not recruiting |
University of Alabama at Birmingham |
2021-04-30 |
| NCT02532790 |
The Research of Standard Diagnosis and Treatment for HSPN With Mild Proteinuria in Children |
https://ClinicalTrials.gov/show/NCT02532790 |
Recruiting |
Nanjing Children’s Hospital |
2020-07-31 |
| NCT02522650 |
A Crossover Pilot Study of the Effect of Amiloride on Proteinuria |
https://ClinicalTrials.gov/show/NCT02522650 |
Recruiting |
Georgetown University |
2021-10-31 |
| NCT02327403 |
Belatacept Conversion in Proteinuric Kidney Transplant Recipients |
https://ClinicalTrials.gov/show/NCT02327403 |
Active, not recruiting |
Brigham and Women’s Hospital |
2020-09-30 |
| NCT02282930 |
Pilot Study of ACTH in the Treatment of Immunoglobulin A (IgA) Nephropathy at High Risk of Progression |
https://ClinicalTrials.gov/show/NCT02282930 |
Completed |
Mayo Clinic |
2018-06-30 |
| NCT02232763 |
Efficacy and Safety of Losartan in Pediatric Chronic Kidney Disease With Tubular Proteinuria |
https://ClinicalTrials.gov/show/NCT02232763 |
Completed |
Seoul National University Hospital |
2016-07-31 |
| NCT02090608 |
Paricalcitol in Fabry Disease |
https://ClinicalTrials.gov/show/NCT02090608 |
Completed |
Federico II University |
2013-12-31 |
| NCT02020785 |
Study of Dietary Additive Phosphorus on Proteinuria and Fibroblast Growth Factor-23 |
https://ClinicalTrials.gov/show/NCT02020785 |
Completed |
Geisinger Clinic |
2015-09-30 |
| NCT02000440 |
A Phase II, Repeat Dose, Proof of Mechanism Study of Losmapimod to Reduce Proteinuria in Patients With Focal Segmental Glomerulosclerosis (FSGS) |
https://ClinicalTrials.gov/show/NCT02000440 |
Completed |
GlaxoSmithKline |
2016-02-29 |
| NCT01967355 |
Prolongation of Pregnancy in Preeclampsia by Therapeutic Lipid Apheresis |
https://ClinicalTrials.gov/show/NCT01967355 |
Completed |
University Hospital Freiburg |
2014-05-08 |
| NCT01831193 |
Effect of Oral Supplementation With Curcumin (Turmeric) in Patients With Proteinuric Chronic Kidney Disease |
https://ClinicalTrials.gov/show/NCT01831193 |
Completed |
Instituto Nacional de Cardiologia Ignacio Chavez |
2014-04-30 |
| NCT01828138 |
Hypertension and Urine Protease Activity in Preeclampsia |
https://ClinicalTrials.gov/show/NCT01828138 |
Completed |
Odense University Hospital |
2015-10-31 |
| NCT01827202 |
RAS Quantification in Patients With Aliskiren or Candesartan |
https://ClinicalTrials.gov/show/NCT01827202 |
Completed |
Medical University of Vienna |
2016-02-29 |
| NCT01738945 |
Effect of Calcium Channel Blocker on the Serum Fibrobalst Growth Factor-23 (FGF-23) Levels in Type-2 Diabetic Patients With Proteinuria Purpose |
https://ClinicalTrials.gov/show/NCT01738945 |
Completed |
Gulhane School of Medicine |
2009-05-31 |
| NCT01703234 |
FGF-23 and Endothelial Dysfunction in Diabetic Proteinuric Patients |
https://ClinicalTrials.gov/show/NCT01703234 |
Completed |
Gulhane School of Medicine |
2009-03-31 |
| NCT01694160 |
Oral Paricalcitol in Renal Transplant Recipients for Reducing Albuminuria |
https://ClinicalTrials.gov/show/NCT01694160 |
Completed |
Oslo University Hospital |
2015-01-31 |
| NCT01601236 |
Acthar for Treatment of Proteinuria in Diabetic Nephropathy Patients |
https://ClinicalTrials.gov/show/NCT01601236 |
Completed |
Mallinckrodt |
2016-01-31 |
| NCT01588795 |
Renal Denervation in Diabetic Nephropathy |
https://ClinicalTrials.gov/show/NCT01588795 |
Completed |
Assistance Publique - Hôpitaux de Paris |
2016-01-31 |
| NCT00810732 |
Effects Of Sitaxsentan On Proteinuria, 24-Hour Blood Pressure, And Arterial Stiffness In Chronic Kidney Disease Subjects |
https://ClinicalTrials.gov/show/NCT00810732 |
Completed |
Pfizer |
2009-03-31 |
| NCT01541267 |
The Effect of Various Types of the Renin-angiotensin-aldosterone System Blockade on Proteinuria |
https://ClinicalTrials.gov/show/NCT01541267 |
Completed |
Medical University of Gdansk |
2011-05-31 |
| NCT01436747 |
Efficacy and Safety of Paricalcitol for Reduction of Proteinuria in Kidney Transplant Recipients |
https://ClinicalTrials.gov/show/NCT01436747 |
Completed |
University Medical Centre Ljubljana |
2014-10-31 |
| NCT01386554 |
Acthar for Treatment of Proteinuria in Membranous Nephropathy Patients |
https://ClinicalTrials.gov/show/NCT01386554 |
Completed |
Mallinckrodt |
2016-11-21 |
| NCT04171778 |
Effects of Whole Food, Plant-Based Nutrition on Chronic Kidney Disease With Proteinuria |
https://ClinicalTrials.gov/show/NCT04171778 |
Recruiting |
University of Rochester |
2021-12-31 |
| NCT04169776 |
Effect of Daily Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) on Proteinuria in Pediatric Patients With Idiopathic Nephrotic Syndrome |
https://ClinicalTrials.gov/show/NCT04169776 |
Recruiting |
Northwell Health |
2020-12-30 |
| NCT04058951 |
Plant Versus Animal Dietary Protein and the Effect on Proteinuria |
https://ClinicalTrials.gov/show/NCT04058951 |
Recruiting |
University of Copenhagen |
2020-03-31 |
| NCT04051957 |
Isosorbide Mononitrate For Anti-Vascular Endothelial Growth Factor (VEGF) Induced Kidney Injury |
https://ClinicalTrials.gov/show/NCT04051957 |
Recruiting |
The University of Texas Health Science Center, Houston |
2020-03-31 |
| NCT03983551 |
Comparing the Renal Effect of Dipeptidyl-peptidase 4 Inhibitors and Sulfonylureas |
https://ClinicalTrials.gov/show/NCT03983551 |
Completed |
Changhua Christian Hospital |
2018-02-10 |
| NCT03573102 |
Effect of Sodium Glucose co Transporter 2 Inhibitor ( SGLT2) on Proteinuria in Diabetic Patients |
https://ClinicalTrials.gov/show/NCT03573102 |
Recruiting |
Ain Shams University |
2020-06-30 |
| NCT03550859 |
HMG-CoA Reductase add-on in Chronic Kidney Disease Patients With Proteinuria |
https://ClinicalTrials.gov/show/NCT03550859 |
Recruiting |
Yuhan Corporation |
2020-08-31 |
| NCT01225445 |
Treatment of Early Immunoglobulin A Nephropathy by Angiotensin Converting Enzyme Inhibitor - A Randomized Controlled Trial |
https://ClinicalTrials.gov/show/NCT01225445 |
Completed |
Chinese University of Hong Kong |
2010-06-30 |
| NCT01219413 |
Influence of Aliskiren on Proteinuria |
https://ClinicalTrials.gov/show/NCT01219413 |
Completed |
Medical University of Gdansk |
2010-07-31 |
| NCT01044771 |
Pilot Study of Raltegravir Switch to Resolve Tenofovir Induced Proteinuria |
https://ClinicalTrials.gov/show/NCT01044771 |
Completed |
Metropolis Medical |
2010-12-31 |
| NCT01029002 |
The Effects of Vitamin D Repletion in Vitamin D Deficient Patients With Stage 3 and 4 Chronic Kidney Disease |
https://ClinicalTrials.gov/show/NCT01029002 |
Completed |
Albert Einstein College of Medicine |
2014-06-30 |
| NCT01028287 |
Adrenocorticotropic Hormone (ACTH) Treatment of Nephrotic Range Proteinuria in Diabetic Nephropathy (NRDN) |
https://ClinicalTrials.gov/show/NCT01028287 |
Completed |
Southeast Renal Research Institute |
2010-12-31 |
| NCT01015937 |
Effect of Turmeric on Diabetic Nephropathy |
https://ClinicalTrials.gov/show/NCT01015937 |
Completed |
Shaheed Faghihi Hospital |
2009-06-30 |
| NCT00983034 |
The Effects of Helicobacter Pylori Eradication on Proteinuria in Patients With Membranous Nephropathy |
https://ClinicalTrials.gov/show/NCT00983034 |
Completed |
Istanbul University |
2008-12-31 |
| NCT00977977 |
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy |
https://ClinicalTrials.gov/show/NCT00977977 |
Recruiting |
National Institutes of Health Clinical Center (CC) |
2021-01-01 |
| NCT00935389 |
Prospective Study of TW in the Treatment of LN Type V With Gross Proteinuria |
https://ClinicalTrials.gov/show/NCT00935389 |
Completed |
Nanjing University School of Medicine |
2011-04-30 |
| NCT00915200 |
N-Acetylcysteine and Milk Thistle for Treatment of Diabetic Nephropathy |
https://ClinicalTrials.gov/show/NCT00915200 |
Completed |
The University of Texas Health Science Center at San Antonio |
2016-04-30 |
| NCT00893425 |
Effect of Renin Angiotensin System Blockade on the Fas Antigen (CD95) and Asymmetric Dimethylarginine (ADMA) Levels in Type-2 Diabetic Patients With Proteinuria |
https://ClinicalTrials.gov/show/NCT00893425 |
Completed |
Gulhane School of Medicine |
2009-03-31 |
| NCT01382303 |
Effect of Pentoxifylline on Proteinuria in Korean Type 2 Diabetic Patients |
https://ClinicalTrials.gov/show/NCT01382303 |
Completed |
Ajou University School of Medicine |
2013-12-20 |
| NCT01265563 |
N-Acetylcysteine and Milk Thistle for Treatment of Diabetic Nephropathy |
https://ClinicalTrials.gov/show/NCT01265563 |
Completed |
VA Office of Research and Development |
2015-02-28 |
| NCT00921570 |
The Effects of Renin Angiotensin System Blockage (RAS), Calcium Channel Blocker and Combined Drugs on TWEAK, PTX3 and FMD Levels in Diabetic Proteinuric Patients With Hypertension |
https://ClinicalTrials.gov/show/NCT00921570 |
Completed |
Gulhane School of Medicine |
2009-05-31 |
| NCT01637259 |
MARCH Renal Substudy |
https://ClinicalTrials.gov/show/NCT01637259 |
Completed |
Kirby Institute |
2015-12-31 |
| NCT00801463 |
Prednisone Plus Tripterygium Wilfordii Treatment of Adult Patients With Idiopathic Focal Segmental Glomerulosclerosis |
https://ClinicalTrials.gov/show/NCT00801463 |
Completed |
Nanjing University School of Medicine |
2011-01-31 |
| NCT03155919 |
Taurine Supplementation and Triathletes |
https://ClinicalTrials.gov/show/NCT03155919 |
Completed |
University of Sao Paulo |
2014-06-30 |
| NCT00768638 |
Study of Atorvastatin Dose Dependent Reduction of Proteinuria |
https://ClinicalTrials.gov/show/NCT00768638 |
Completed |
Laval University |
2014-05-31 |
| NCT00722215 |
Endothelin Receptor Antagonism in Proteinuric Nephropathy |
https://ClinicalTrials.gov/show/NCT00722215 |
Completed |
University of Edinburgh |
2007-11-30 |
| NCT00674596 |
The Effect of Renin Angiotensin System Blockage (RAS) Blockade On PTX3 Levels In Diabetic Patients With Proteinuria |
https://ClinicalTrials.gov/show/NCT00674596 |
Completed |
Gulhane School of Medicine |
2008-03-31 |
| NCT00663949 |
Assessment of the Effect of Captopril Versus Combination of Captopril and Pentoxifylline on Reducing Proteinuria in Type 2 Diabetic Nephropathy |
https://ClinicalTrials.gov/show/NCT00663949 |
Completed |
Shiraz University of Medical Sciences |
2007-12-31 |
| NCT00572663 |
Optimalization of Nephroprotection Using N-Acetylcysteine |
https://ClinicalTrials.gov/show/NCT00572663 |
Completed |
Medical University of Gdansk |
NA |
| NCT00568178 |
An Extension Study Designed to Assess Effects of Losartan on Proteinuria in Pediatric Populations (MK-0954-326 AM1,EXT1(AM2)) |
https://ClinicalTrials.gov/show/NCT00568178 |
Completed |
Merck Sharp & Dohme Corp. |
2008-09-01 |
| NCT00550095 |
To Assess the Effects of Valsartan on Albuminuria/Proteinuria in Hypertensive Patients With Type 2 Diabetes Mellitus |
https://ClinicalTrials.gov/show/NCT00550095 |
Completed |
Novartis |
2009-11-30 |
| NCT00528385 |
Optimalization of Nephroprotection Using Agents Inhibiting Renin-Angiotensin-Aldosterone System |
https://ClinicalTrials.gov/show/NCT00528385 |
Completed |
Medical University of Gdansk |
NA |
| NCT00507494 |
Influence of Pioglitazone for Renal Transplant Function in Diabetics |
https://ClinicalTrials.gov/show/NCT00507494 |
Completed |
Technische Universität Dresden |
2009-09-30 |
| NCT00498537 |
Spironolactone for Reducing Proteinuria in Diabetic Nephropathy |
https://ClinicalTrials.gov/show/NCT00498537 |
Completed |
VA Office of Research and Development |
2005-12-31 |
| NCT00493727 |
Use of Mucomyst to Ameliorate Oxidant Stress in Diabetics With Proteinuria |
https://ClinicalTrials.gov/show/NCT00493727 |
Completed |
VA Office of Research and Development |
2007-12-31 |
| NCT00464503 |
Statins and the Urinary Proteome |
https://ClinicalTrials.gov/show/NCT00464503 |
Completed |
Universiteit Antwerpen |
2007-10-31 |
| NCT00419835 |
Effect of Enalapril and Losartan Association Therapy on Proteinuria and Inflammatory Biomarkers in Diabetic Nephropathy: a Clinical Trial on Type 2 Diabetes Mellitus |
https://ClinicalTrials.gov/show/NCT00419835 |
Completed |
University of Sao Paulo |
2007-09-30 |
| NCT00367562 |
Inhibition of the Renin Angiotensin System Plus Corticosteroids for the Treatment of Proteinuria in IGA Nephropathy |
https://ClinicalTrials.gov/show/NCT00367562 |
Completed |
Hospital Britanico |
NA |
| NCT00362960 |
Olmesartan Medoxomil and Diabetic Nephropathy |
https://ClinicalTrials.gov/show/NCT00362960 |
Completed |
Daiichi Sankyo, Inc. |
NA |
| NCT00324675 |
Effects of Rosiglitazone on Renal Hemodynamics and Proteinuria of Type 2 Diabetic Patients With Renal Insufficiency Due to Overt Diabetic Nephropathy |
https://ClinicalTrials.gov/show/NCT00324675 |
Completed |
Technische Universität Dresden |
2008-12-31 |
| NCT00296400 |
Prospective Evaluation of Proteinuria and Renal Function in Non-diabetic Patients With Progressive Renal Disease |
https://ClinicalTrials.gov/show/NCT00296400 |
Completed |
AstraZeneca |
2009-06-30 |
| NCT00296374 |
Prospective Evaluation of Proteinuria and Renal Function in Diabetic Patients With Progressive Renal Disease |
https://ClinicalTrials.gov/show/NCT00296374 |
Completed |
AstraZeneca |
2009-03-31 |
| NCT00242346 |
High Doses of Candesartan Cilexetil on the Reduction of Proteinuria |
https://ClinicalTrials.gov/show/NCT00242346 |
Completed |
AstraZeneca |
NA |
| NCT00241085 |
Effect of Valsartan on Proteinuria in Patients With Hypertension and Diabetes Mellitus |
https://ClinicalTrials.gov/show/NCT00241085 |
Completed |
Novartis |
2005-08-31 |
| NCT00234871 |
Tarka® vs. Lotrel® in Hypertensive, Diabetic Subjects With Renal Disease (TANDEM) |
https://ClinicalTrials.gov/show/NCT00234871 |
Completed |
Abbott |
2005-03-31 |
| NCT00199927 |
Statins in Proteinuric Nephropathies |
https://ClinicalTrials.gov/show/NCT00199927 |
Completed |
Mario Negri Institute for Pharmacological Research |
2007-12-31 |
| NCT00141453 |
ORIENT: Olmesartan Reducing Incidence of End Stage Renal Disease in Diabetic Nephropathy Trial |
https://ClinicalTrials.gov/show/NCT00141453 |
Completed |
Daiichi Sankyo, Inc. |
2008-08-31 |
| NCT00106561 |
Using the Drug Spironolactone to Test If It Reduces Protein Leakage From the Kidney |
https://ClinicalTrials.gov/show/NCT00106561 |
Completed |
Melbourne Health |
NA |
| NCT00097955 |
Safety and Efficacy of Aliskiren When Added to Standardized Losartan and Optimal Antihypertensive Therapy in Patients With Hypertension, Type 2 Diabetes and Proteinuria |
https://ClinicalTrials.gov/show/NCT00097955 |
Completed |
Novartis |
2007-04-30 |
| NCT00067990 |
Angiotensin II Blockade for Chronic Allograft Nephropathy |
https://ClinicalTrials.gov/show/NCT00067990 |
Completed |
University of Minnesota |
2011-06-30 |
| NCT00572312 |
Optimalization of Nephroprotection Using Atorvastatin (Sortis) |
https://ClinicalTrials.gov/show/NCT00572312 |
Completed |
Medical University of Gdansk |
NA |
| NCT00001959 |
Pirfenidone to Treat Kidney Disease (Focal Segmental Glomerulosclerosis) |
https://ClinicalTrials.gov/show/NCT00001959 |
Completed |
National Institutes of Health Clinical Center (CC) |
2008-10-31 |